OxyContin maker Purdue Pharma is settlement talks over opioid cases
State attorneys general and lawyers representing local governments said Tuesday they are in active settlement talks with Purdue Pharma, the maker of the prescription painkiller OxyContin that is facing billions of dollars in potential liability for its role in the nation's opioid crisis. Purdue has been cast by attorneys and addiction experts as a main villain in the crisis for producing a blockbuster drug while understating its addiction risk. Purdue Pharma and its owners are reportedly looking to settle more than 2,000 opioid cases in a deal between $10 billion and $12 billion.
State attorneys general and lawyers representing local governments said Tuesday they are in active settlement talks with Purdue Pharma, the maker of the prescription painkiller OxyContin that is facing billions of dollars in potential liability for its role in the nation's opioid crisis. Purdue has been cast by attorneys and addiction experts as a main villain in the crisis for producing a blockbuster drug while understating its addiction risk. Purdue Pharma and its owners are reportedly looking to settle more than 2,000 opioid cases in a deal between $10 billion and $12 billion.
No hay comentarios:
Publicar un comentario